RES ameliorates motor dysfunction in the A53T αSYN mouse model of PD and reduces striatal αSYN levels, glial activation, and TNF-α and IL-1β levels in an MPTP mouse model of PD [149]. The gene discussed is TNF; the disease is Parkinson disease.